CoChat

Gepirone in the Treatment of Major Depression

JENKINS, STEPHEN W., ROBINSON, DONALD S., FABRE, LOUIS F., ANDARY, JOSEPH J., MESSINA, MARIANNE E., REICH, LINDA A. · 1990 · Journal of Clinical Psychopharmacology
Cited by 71

The DOI matches its Crossref record.

Abstract

Gepirone is a serotonin (5-hydroxytryptamine, 5-HT) type1A receptor agonist and a pharmacologic analogue of buspirone. Two double-blind, placebo-controlled studies show the efficacy of gepirone in the treatment of major depression. Study 1 demonstrates gepirone's superiority over placebo in an 8-week acute treatment of patients with major depression, including the melancholic subtype. Gepirone's antidepressant dose range is tentatively established at 5-30 mg/day. Study 2 reveals the benefit of gepirone compared with placebo in 4-week continuation therapy of patients with major depression who initially responded to 6 weeks of open therapy with gepirone. Analysis of Hamilton Rating Scale for Depression item scores show gepirone especially improves scores on items of core depression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00004714-199006001-00014

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 71

Metadata

Authors
JENKINS, S. W., ROBINSON, D. S., FABRE, L. F., ANDARY, J. J., MESSINA, M. E., & REICH, L. A.
Venue
Journal of Clinical Psychopharmacology
Published
1990-06
Volume
10
Issue
Supplement
Pages
77S-85S
ISSN
0271-0749 (ISSN-L)
OpenAlex
W2321617757
Cited by
71
References
0
FWCI
6.29
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gepirone in the Treatment of Major Depression. https://app.cochat.ai/papers/10.1097/00004714-199006001-00014
The paper
JENKINS, S. W., ROBINSON, D. S., FABRE, L. F., ANDARY, J. J., MESSINA, M. E., & REICH, L. A. (1990). Gepirone in the Treatment of Major Depression. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/00004714-199006001-00014

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.